Castle Biosciences (CSTL) Capital Expenditures Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 50.00% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 3.87% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -3.27% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -72.44% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -33.33% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 1.48% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -10.56% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 18.75% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 0.92% |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | 287.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 287.16% |
| Dec 31, 2025 | -28.73% |
| Sep 30, 2025 | 245.17% |
| Jun 30, 2025 | -73.65% |
| Mar 31, 2025 | 360.23% |
| Dec 31, 2024 | -647.30% |
| Sep 30, 2024 | -29.91% |
| Jun 30, 2024 | 624.21% |
| Mar 31, 2024 | -79.06% |
| Dec 31, 2023 | 254.88% |
| Sep 30, 2023 | 188.98% |
| Jun 30, 2023 | -493.07% |
| Mar 31, 2023 | 10,331.25% |
| Dec 31, 2022 | 91.75% |
| Jun 30, 2022 | -97.95% |
| Mar 31, 2022 | -95.73% |
| Dec 31, 2021 | -114,334.62% |
| Jun 30, 2021 | 1,747.04% |
| Mar 31, 2021 | 50.00% |
| Dec 31, 2020 | -92.51% |